Axogen, Inc. Investment Income, Net
Axogen, Inc. (AXGN) reported Investment Income, Net of $786.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeNet · last filed 2026-07-29
- Axogen, Inc. investment income, net for the quarter ending 2026-06-30 was $786.00K, a 249.33% increase year-over-year.
- Axogen, Inc. investment income, net for the quarter ending 2026-03-31 was $768.00K, a 182.35% increase year-over-year.
- Axogen, Inc. investment income, net for the quarter ending 2025-12-31 was $352.00K, a 8.31% increase year-over-year.
- Axogen, Inc. investment income, net for the quarter ending 2025-09-30 was $319.00K, a 7.77% increase year-over-year.
- Axogen, Inc. investment income, net for fiscal 2025 was $1.17M, a 2.37% increase from fiscal 2024.
- Axogen, Inc. investment income, net for fiscal 2024 was $1.14M, a 23.27% decline from fiscal 2023.
- Axogen, Inc. investment income, net for fiscal 2023 was $1.49M, a 161.34% increase from fiscal 2022.
- Axogen, Inc. investment income, net for fiscal 2022 was $569.00K, a 511.83% increase from fiscal 2021.
| Period end | Investment Income, Net 3 month | Investment Income, Net 6 month | Investment Income, Net 9 month | Investment Income, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | $786.00K 10-Q · filed 2026-07-29 | $1.55M 10-Q · filed 2026-07-29 | $1.91M derived: sum of 3 quarters · filed 2026-07-29 | $2.23M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $768.00K 10-Q · filed 2026-04-28 | $1.12M derived: sum of 2 quarters · filed 2026-04-28 | $1.44M derived: sum of 3 quarters · filed 2026-04-28 | $1.66M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $352.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $671.00K derived: sum of 2 quarters · filed 2026-02-24 | $896.00K derived: sum of 3 quarters · filed 2026-07-29 | $1.17M 10-K · filed 2026-02-24 |
| 2025-09-30 | $319.00K 10-Q · filed 2025-10-29 | $544.00K derived: sum of 2 quarters · filed 2026-07-29 | $816.00K 10-Q · filed 2025-10-29 | $1.14M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $225.00K 10-Q · filed 2026-07-29 | $497.00K 10-Q · filed 2026-07-29 | $822.00K derived: sum of 3 quarters · filed 2026-07-29 | $1.12M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $272.00K 10-Q · filed 2026-04-28 | $597.00K derived: sum of 2 quarters · filed 2026-04-28 | $893.00K derived: sum of 3 quarters · filed 2026-04-28 | $1.12M derived: sum of 4 quarters · filed 2026-04-28 |
| 2024-12-31 | $325.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $621.00K derived: sum of 2 quarters · filed 2026-02-24 | $848.00K derived: sum of 3 quarters · filed 2026-02-24 | $1.14M 10-K · filed 2026-02-24 |
| 2024-09-30 | $296.00K 10-Q · filed 2025-10-29 | $523.00K derived: sum of 2 quarters · filed 2025-10-29 | $816.00K 10-Q · filed 2025-10-29 | $1.15M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $227.00K 10-Q · filed 2025-08-05 | $520.00K 10-Q · filed 2025-08-05 | $856.00K derived: sum of 3 quarters · filed 2026-02-24 | $1.22M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $293.00K 10-Q · filed 2025-05-08 | $629.00K derived: sum of 2 quarters · filed 2026-02-24 | $996.00K derived: sum of 3 quarters · filed 2026-02-24 | $1.23M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $336.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $703.00K derived: sum of 2 quarters · filed 2026-02-24 | $938.00K derived: sum of 3 quarters · filed 2026-02-24 | $1.49M 10-K · filed 2026-02-24 |
| 2023-09-30 | $367.00K 10-Q · filed 2024-11-07 | $602.00K derived: sum of 2 quarters · filed 2024-11-07 | $1.15M 10-Q · filed 2024-11-07 | $1.55M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $235.00K 10-Q · filed 2024-08-08 | $784.00K 10-Q · filed 2024-08-08 | $1.18M derived: sum of 3 quarters · filed 2025-02-26 | $1.37M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $549.00K 10-Q · filed 2024-05-02 | $946.00K derived: sum of 2 quarters · filed 2025-02-26 | $1.13M derived: sum of 3 quarters · filed 2025-02-26 | $1.16M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | $397.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $583.00K derived: sum of 2 quarters · filed 2025-02-26 | $615.00K derived: sum of 3 quarters · filed 2025-02-26 | $569.00K 10-K · filed 2025-02-26 |
| 2022-09-30 | $186.00K 10-Q · filed 2023-11-07 | $218.00K derived: sum of 2 quarters · filed 2023-11-07 | $172.00K 10-Q · filed 2023-11-07 | $185.00K derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-06-30 | $32.00K 10-Q · filed 2023-08-08 | -$15.00K 10-Q · filed 2023-08-08 | -$1.00K derived: sum of 3 quarters · filed 2024-03-05 | $16.00K derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-03-31 | -$46.00K 10-Q · filed 2023-05-09 | -$33.00K derived: sum of 2 quarters · filed 2024-03-05 | -$16.00K derived: sum of 3 quarters · filed 2024-03-05 | $13.00K derived: sum of 4 quarters · filed 2024-03-05 |
| 2021-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $30.00K derived: sum of 2 quarters · filed 2024-03-05 | $59.00K derived: sum of 3 quarters · filed 2024-03-05 | $93.00K 10-K · filed 2024-03-05 |
| 2021-09-30 | $17.00K 10-Q · filed 2022-11-08 | $46.00K derived: sum of 2 quarters · filed 2022-11-08 | $80.00K 10-Q · filed 2022-11-08 | $109.00K derived: sum of 4 quarters · filed 2023-03-14 |
| 2021-06-30 | $29.00K 10-Q · filed 2022-08-05 | $63.00K 10-Q · filed 2022-08-05 | $92.00K derived: sum of 3 quarters · filed 2023-03-14 | $120.00K derived: sum of 4 quarters · filed 2023-03-14 |
| 2021-03-31 | $34.00K 10-Q · filed 2022-05-05 | $63.00K derived: sum of 2 quarters · filed 2023-03-14 | $91.00K derived: sum of 3 quarters · filed 2023-03-14 | $328.00K derived: sum of 4 quarters · filed 2023-03-14 |
| 2020-12-31 | $29.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $57.00K derived: sum of 2 quarters · filed 2023-03-14 | $294.00K derived: sum of 3 quarters · filed 2023-03-14 | $605.00K 10-K · filed 2023-03-14 |
| 2020-09-30 | $28.00K 10-Q · filed 2021-11-04 | $265.00K derived: sum of 2 quarters · filed 2021-11-04 | $576.00K 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $237.00K 10-Q · filed 2021-08-05 | $548.00K 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | $311.00K 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | $2.36M 10-K · filed 2022-02-25 | |||
| 2018-12-31 | $1.52M 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |